ZTS
Zoetis
Stock NYSE – Stock Market Prices, News & Analysis
Zoetis Inc is a global leader in the discovery, development, manufacture, and marketing of medicines and vaccines for pets and livestock.
Zoetis
ZTS
Zoetis Inc is a global leader in the discovery, development, manufacture, and marketing of medicines and vaccines for pets and livestock.
Price history of Zoetis
Price history of Zoetis
Performance & Momentum
Zoetis keeps dividend despite cautious 2026 outlook
Zoetis Inc. (ZTS) declared a $0.53 dividend per share for Q2 2026, ensuring consistent liquidity returns for shareholders. This announcement comes amid modest financial outlooks for 2026, driven by fewer veterinary visits and increased regulatory scrutiny. Over the past year, the stock has dropped significantly by 26.16%, although short-term trends are improving. Analysts remain cautious but optimistic, highlighting potential earnings beat opportunities.
Strategic Analysis
Zoetis • 2026
Zoetis is a global leader specialized in animal health, offering a diversified range of medications and vaccines for both companion animals and livestock. The company focuses on innovation and global presence to strengthen its position in a resilient sector against economic cycles. Maintaining its dividend despite a cautious outlook for 2026 demonstrates a strategy of financial stability and confidence in its long-term model.
Strengths
- Dominant position in the global animal health market
- Diversified portfolio covering companion animals and livestock
- Strong dividend policy enhancing attractiveness for investors
Weaknesses
- Cautious 2026 outlook potentially limiting investor enthusiasm
- Recent negative stock performance over several time horizons
Momentum
The momentum is currently weak, reflecting uncertainties related to the cautious forecasts and degraded stock performance in the medium term. The preservation of the dividend may alleviate short-term pressures by strengthening shareholder confidence, but the trend remains one to monitor closely given the moderate outlook.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
